Evidence for the interaction of acetylcholinesterase inhibitors with "catalytic" and "extra-catalytic" sites on the insolubilized enzyme.
Friboulet
A
A
Laboratoire de Technologie Enzymatique CNRS UA 523, Compiègne, France.
Goudou
D
D
Taylor
P
P
Rieger
F
F
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D008815:Mice, Inbred Strains; D009132:Muscles / Q000201:enzymology*; D063086:Organothiophosphates / Q000378:metabolism / Q000494:pharmacology*; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D011485:Protein Binding
D002800:Cholinesterase Inhibitors; D063086:Organothiophosphates; D009946:Organothiophosphorus Compounds; C045909:O-ethyl-S(2)-diisopropylaminoethylmethyl phosphorothiolate; D000110:Acetylcholinesterase